Holger Wenzlaff

Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations

Heiko von der Leyen, Ulrike Mende, Wilfried Meyer et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1991 · 57 citations

Medicine, Cardiology, Pharmacology +16

Phosphodiesterase inhibition in ventricular cardiomyocytes from guinea‐pig hearts

Thomas D. Bethke, Wilfried Meyer, Wilhelm Schmitz et al. · British Journal of Pharmacology · 1992 · 32 citations · Full text

Medicine, Biochemistry, Pharmacology +9

Positive inotropic effects of the calcium sensitizer CGP 48506 in failing human myocardium.

Joachim Neumann, Thomas Eschenhagen, I L Grupp et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 29 citations

Medicine, Cardiology, Pharmacology +12

Characterization of Biochemical Effects of CGS 21680C, an A2-Adenosine Receptor Agonist, in the Mammalian Ventricle

Peter Boknı́k, Joachim Neumann, Wilhelm Schmitz et al. · Journal of Cardiovascular Pharmacology · 1997 · 25 citations

Life Sciences, Biochemistry, Pharmacology +17

High Selectivity for Inhibition of Phosphodiesterase III and Positive Inotropic Effects of MCI-154 in Guinea Pig Myocardium

T.D. Bethke, Wieland Meyer, Wilhelm Schmitz et al. · Journal of Cardiovascular Pharmacology · 1993 · 24 citations

Medicine, Pharmacology, Physiology +13